Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intravenous remifentanil vs dexmedetomidine for hemodynamics and pain in cataract surgery
IRCT20220302054164N2Phase 3Completed
- Sponsor
- Arak University of Medical Sciences
- Start
- Feb 2023
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial in cataract comparing Remifentanil infusion with Dexmedetomidine infusion (2 arms). Primary endpoints: Hemodynamic changes during cataract surgery and Perioperative pain. Started Feb 2023; status: completed.
02
Drugs
remifentanildexmedetomidine
03
Conditions
cataract
Beyond the preview
Go deeper on IRCT20220302054164N2.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20220302054164N2.